Abstract
Clinical case reports (CCRs) have a time-honored tradition in serving as an important means of sharing clinical experiences on patients presenting with atypical disease phenotypes or receiving new therapies. However, the huge amount of accumulated case reports are isolated, unstructured, and heterogeneous clinical data, posing a great challenge to clinicians and researchers in mining relevant information through existing indexing tools. In this investigation, in order to render CCRs more findable, accessible, interoperable, and reusable (FAIR) by the biomedical community, we created a resource platform, including the construction of a test dataset consisting of 1000 CCRs spanning 14 disease phenotypes, a standardized metadata template and metrics, and a set of computational tools to automatically retrieve relevant medical information and to analyze all published PubMed clinical case reports with respect to trends in publication journals, citations impact, MeSH Terms, drug use, distributions of patient demographics, and relationships with other case reports and databases. Our standardized metadata template and CCR test dataset may be valuable resources to advance medical science and improve patient care for researchers who are using machine learning approaches with a high-quality dataset to train and validate their algorithms.
Introduction
Since the era of Louis Pasteur, clinical case reports (CCRs) have functioned as the "first responders" of medical literature. They document rare diseases, unexpected side effects, and novel therapeutic approaches that often precede formal clinical trials. However, the sheer volume of these reports has become a double-edged sword. As of 2017, PubMed hosted approximately 1.8 million case reports, with over half a million published in the last decade alone.
Despite their clinical value, CCRs remain largely "hidden treasures." Because they are typically written as free-form narratives, they are often isolated, unstructured, and heterogeneous. Standard indexing tools, such as PubMed’s Medical Subject Headings (MeSH), often capture only surface-level keywords, missing the granular clinical context—such as specific lab values, lifestyle factors, or family histories—necessary for deep data mining. This study aims to bridge this gap by making CCRs "FAIR": Findable, Accessible, Interoperable, and Reusable.
The Metadata Framework
To transform narrative text into structured, machine-readable data, the researchers developed a standardized 35-item metadata template. These items are categorized into three functional groups:
- Identification (10 items): Basic bibliographic information including title, author, and DOI.
- Medical Content (21 items): The core clinical data, covering signs/symptoms, comorbidities, diagnostic procedures, and drug therapies.
- Acknowledgements (4 items): Information regarding funding and references.
To evaluate the effectiveness of this template, the team developed a scoring system (0–35 points) to measure the "information density" of a report. This metric quantifies how much essential clinical information is captured by the metadata compared to the full text.
Methodology and Datasets
The investigation utilized two distinct data sources to validate the framework:
- The 1000 CCR Test Dataset: A manually curated collection of 1,000 case reports spanning 14 disease phenotypes (e.g., oncology, cardiology, infectious diseases). This dataset serves as a high-quality "ground truth" for training and validating future machine learning algorithms.
- The PubMed Corpus: A massive longitudinal dataset comprising 1,374,513 English-language case reports indexed between 1945 and 2015. This corpus was used to analyze publication trends, citation impacts, and disease distributions.
Key Insights and Results
The Metadata Gap
One of the study's most significant findings is the "information loss" occurring in current indexing systems. While the full text of the analyzed reports contained approximately 68.4% of the essential metadata items defined in the 35-item template, existing PubMed metadata only captured 47.1%. This discrepancy highlights a major barrier to precision medicine; if the data isn't indexed, it effectively remains inaccessible for large-scale research.
Citation Trends and Impact
The study addressed the common criticism that case reports have low scientific impact. While 54% of reports in the PubMed corpus have never been cited, a small but significant "elite" group (1.7%, or roughly 23,000 reports) received more than 10 citations. This suggests that high-quality, well-documented cases can indeed become foundational pieces of biomedical knowledge.
Disease Distribution and Growth
The analysis revealed that Cancer (27.5%), Neurological diseases (21.0%), and Cardiovascular diseases (19.8%) are the most frequently published topics. Interestingly, while the absolute number of CCRs is growing, their growth rate lags behind the overall rate of scientific publication. This may be due to the inherent scarcity of rare disease cases or a shift in journal preferences toward study designs with higher immediate citation potential.
Conclusion and Future Directions
The transition of CCRs from simple teaching tools to interoperable data points is essential for the future of "omics" research and clinical trials. By standardizing metadata, researchers can link individual patient stories to broader genomic and proteomic datasets.
The primary challenge remains scalability. Manual curation of millions of reports is unfeasible. However, the 1,000-report test set created in this study provides the necessary foundation for autonomous curation. By using this high-quality dataset to train Natural Language Processing (NLP) and machine learning models, the biomedical community can begin to automatically extract structured insights from the entire PubMed corpus. Future work will also focus on integrating classification systems like the International Classification of Diseases (ICD) to further refine the "Medical Content" category and enhance the global utility of clinical case data.
Summary updated